Early detection and prognosis of colon cancer metastasis are critical for patient survival, yet remain challenging due to the interaction of clinical, pathological, and genetic factors. We present a machine learning simulator for colon cancer liver metastasis risk prediction that estimates 3-year mortality by integrating genomic, mutational, and clinical data, providing individualized risk scores to support oncologists and researchers.

This tool bridges clinical and genomic data with practical applications, helping improve prognosis assessment in metastatic colon cancer.

Healthcare professionals can test it with Neural Designer.

Inputs:

Type of Adenocarcinoma:
Metastasis primary site count:
Microsatellite instability score:
Microsatellite instability type:
Mutation count:
Cancer microsatellite subtype:
Tumour mutational burden:
KIT mutation count:
CARD11 mutation count:
RB1 mutation count:
WT1 mutation count:
PLCG2 mutation count:
DNMT1 mutation count:
BRD4 mutation count:
PIK3R1 mutation count:
IRS2 mutation count:
SESN1 mutation count:
NPM1 mutation count:
Liver metastasis risk:6.33%

Related posts